바로가기
메인메뉴로 바로가기
서브메뉴 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기

진료과안내

호흡기내과

장태원 사진
Kosin University Gospel Hospital
호흡기내과   장태원

진료과

호흡기내과

 

전문진료분야

폐암,천식,만성기관지염,결핵,폐렴,만성폐쇄성폐질환

서울경제인터뷰 바로가기 클릭↓
"폐암 4기 진단에 망연자실하던 60대 환자, '렉라자' 무상 공급 덕에 희망 찾아"

 

약력

고신대학 의과대학 교수
영국 University College London Hospital 연수
경북대학교 의학박사
고신대학교병원 내과 수련
경북대학교 의과대학 졸업

 

Updated date : 2023.08.08

학회활동 및 논문

[학회활동]
현 대한폐암학회 회장, 법제윤리이사, 연구이사
대한내과 학회 회원
대한결핵및호흡기학회 회원
대한폐암학회 회원
대한암학회 회원
분자폐암연구화 회장 역임
Fellow of American College of Chest Physicians
Board of Asia Pacific Bronchology Society.
Board of Korean Bronchoesophagological Society

[논문]
1. Jehun Kim, Tae Won Jang, Chang Min Choi, Mi Hyun Kim, Sung Yong Lee, Cheol Kyu Park, Yoon Soo Chang, Kye Young Lee, Seung Joon Kim, Sei Hoon Yang, Jeong Seon Ryu, Jeong Eun Lee, Shin Yup Lee, Chan Kwon Park, Sang Hoon Lee, Seung Hun Jang, Seong Hoon Yoon. Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors. Cancer Res Treat. 2023;55(1):112-122
2. Jang Ho Lee, Eun Young Kim, heol-Kyu Park, Shin Yup Lee, Min Ki Lee, Seong-Hoon Yoon, Jeong Eun Lee, Sang Hoon Lee, Seung Joon Kim, Sung Yong Lee, Jun Hyeok Lim, Tae-Won Jang, Seung Hun Jang, Kye Young Lee, Seung Hyeun Lee, Sei Hoon Yang, Dong Won Park, Chan Kwon Park, Hye Seon Kang, Chang Dong Yeo, Chang-Min Choi, Jae Cheol Lee. Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation?Positive Non?Small Cell Lung Cancer. Cancer Res Treat. 2023 Jan; 55(1): 112?122
3. Taeyun Kim, Sang Jin Lee, Tae-Won Jang. Application of several machine learning algorithms for the prediction of afatinib treatment outcome in advanced-stage EGFR-mutated non-small-cell lung cancer. Thorac Cancer, 2022,13:3353-3361.
4. Juwhan Choi, Jeong Eun Lee, Chang-Min Choi, In-Jae Oh, Kye Young Lee, Tae Won Jang, Seung Hyeun Lee, Eun Young Kim, Dong Won Park, Sun Hyo Park, Sung Yong Lee . A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation-positive non-small cell lung cancer (stage III) who have not progressed following definitive, platinum-based, chemoradiation therapy (PLATINUM trial). Thorac Cancer, 2022,13:3413-3335.
5. Cheol-Kyu Park, Hyung-Joo Oh, Seung Soo Yoo, Shin Yup Lee, Sang Hoon Lee, Eun Young Kim, Sung Yong Lee, Juwhan Choi, Min Ki Lee, Mi-Hyun Kim, Tae Won Jang, Chaeuk Chung, In-Jae Oh, Young-Chul Kim. Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial. Transl Lung Cancer Res. 2022 Aug; 11(8): 1606?1618.
6. Jehun Kim, Taeyun Kim, Tae Won Jang, Hee Kang, Mi Hyun Kim, Seong Hoon Yoon, Choon-Hee Son, Hyun-Kyung Lee, Hyun-Kuk Kim, Shin Yup Lee, Kyeong Choel Shin, Ji-Yeon Han, Eun-Ju Kang. Clinical outcomes of hyperprogression based on volumetry in non-small cell lung cancer after immune checkpoint inhibitor treatment, Thorac Cancer. 2022 13;2170-2179

진료시간표

구분
오전 외래   외래 외래    
오후     외래